T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Banco Santander Chile
BSAC
$16B
| $4.67M | ﹤0.01% |
176,235
-42,315
| -19% | -$1.04M |
|
1402
Park Hotels & Resorts
PK
$2.99B
| $4.61M | ﹤0.01% |
415,923
+74,477
| +22% | +$837K |
|
1403
Teleflex
TFX
$5.82B
| $4.59M | ﹤0.01% |
37,534
+2,137
| +6% | +$259K |
|
1404
KBR
KBR
$4.8B
| $4.59M | ﹤0.01% |
97,089
-118,191
| -55% | -$5.73M |
|
1405
Carriage Services
CSV
$535M
| $4.59M | ﹤0.01% |
103,011
+32,466
| +46% | +$1.47M |
|
1406
iShares Russell Mid-Cap Growth ETF
IWP
$21.1B
| $4.57M | ﹤0.01% |
32,086
| – | – |
|
1407
Allogene Therapeutics
ALLO
$683M
| $4.56M | ﹤0.01% |
3,677,474
-353,398
| -9% | -$421K |
|
|
CBIO
1408
Crescent Biopharma
CBIO
$610M
| $4.56M | ﹤0.01% |
+383,595
| New | +$5.09M |
|
|
SPR
1409
DELISTED
Spirit AeroSystems
SPR
| $4.56M | ﹤0.01% |
118,109
+7,483
| +7% | +$299K |
|
1410
Kite Realty
KRG
$5.27B
| $4.53M | ﹤0.01% |
203,271
+9,331
| +5% | +$208K |
|
1411
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
| $4.53M | ﹤0.01% |
96,775
+1,735
| +2% | +$77.1K |
|
1412
Southwest Gas
SWX
$6.67B
| $4.53M | ﹤0.01% |
57,834
+2,678
| +5% | +$209K |
|
1413
UiPath
PATH
$8.64B
| $4.51M | ﹤0.01% |
337,179
+11,178
| +3% | +$132K |
|
1414
Meritage Homes
MTH
$4.8B
| $4.5M | ﹤0.01% |
62,150
+2,875
| +5% | +$214K |
|
|
KREF
1415
KKR Real Estate Finance Trust
KREF
$493M
| $4.47M | ﹤0.01% |
496,666
+8,513
| +2% | +$79.1K |
|
1416
Iovance Biotherapeutics
IOVA
$2.95B
| $4.47M | ﹤0.01% |
2,058,018
-56,172
| -3% | -$133K |
|
|
LBRX
1417
LB Pharmaceuticals
LBRX
$1.46B
| $4.46M | ﹤0.01% |
+282,644
| New | +$4.48M |
|
|
ETOR
1418
eToro Group
ETOR
$2.3B
| $4.46M | ﹤0.01% |
107,952
-350,974
| -76% | -$18.1M |
|
1419
EverQuote
EVER
$867M
| $4.45M | ﹤0.01% |
194,393
+180,483
| +1,298% | +$4.36M |
|
1420
Spire
SR
$4.89B
| $4.42M | ﹤0.01% |
54,173
+3,130
| +6% | +$238K |
|
1421
Arcosa
ACA
$7.12B
| $4.41M | ﹤0.01% |
47,094
+2,236
| +5% | +$208K |
|
1422
Graphic Packaging
GPK
$3.46B
| $4.41M | ﹤0.01% |
225,494
+12,221
| +6% | +$266K |
|
1423
AutoNation
AN
$6.9B
| $4.39M | ﹤0.01% |
20,078
+1,404
| +8% | +$296K |
|
1424
Vail Resorts
MTN
$5.29B
| $4.38M | ﹤0.01% |
29,298
+1,881
| +7% | +$292K |
|
1425
Macerich
MAC
$6.99B
| $4.37M | ﹤0.01% |
240,294
+12,242
| +5% | +$212K |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.